 | Up a level |
Younossi, Zobair M. and Yilmaz, Yusuf and El-Kassas, Mohamed and Duseja, Ajay and Hamid, Saeed and Esmat, Gamal and Mendez-Sanchez, Nahum and Chan, Wah Kheong and Singal, Ashwani K. and Lam, Brian and Felix, Sean and Younossi, Elena and Verma, Manisha and Price, Jillian K. and Nader, Fatema and Younossi, Issah and Racila, Andrei and Stepanova, Maria (2022) The impact of the COVID-19 pandemic on patients with chronic liver disease: Results from the Global Liver Registry. Hepatology Communications, 6 (10). pp. 2860-2866. DOI https://doi.org/10.1002/hep4.2048.
Lau, George and Yu, Ming-Lung and Wong, Grace and Thompson, Alexander and Ghazinian, Hasmik and Hou, Jin-Lin and Piratvisuth, Teerha and Jia, Ji-Dong and Mizokami, Masashi and Cheng, Gregory and Chen, Guo-Feng and Liu, Zhen-Wen and Baatarkhuu, Oidov and Cheng, Ann Lii and Ng, Woon Leung and Lau, Patrick and Mok, Tony and Chang, Jer-Ming and Hamid, Saeed and Dokmeci, A. Kadir and Gani, Rino A. and Payawal, Diana A. and Chow, Pierce and Park, Joong-Won and Strasser I, Simone and Mohamed, Rosmawaiti and Win, Khin Maung and Tawesak, Tanwandee and Sarin, Shiv Kumar and Omata, Masao APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy. HEPATOLOGY INTERNATIONAL, 15 (5). pp. 1031-1048.
